VSee Health, Inc.
VSEE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.10 | 0.05 | 0.04 | 0.01 |
| FCF Yield | -7.55% | -1.72% | -2.31% | -13.87% |
| EV / EBITDA | 11.53 | -12.84 | -8.60 | -12.60 |
| Quality | ||||
| ROIC | 100.63% | 86.19% | 269.03% | -40.76% |
| Gross Margin | 52.08% | 46.86% | 56.00% | 62.96% |
| Cash Conversion Ratio | 2.60 | 0.12 | 0.11 | 0.53 |
| Growth | ||||
| Revenue 3-Year CAGR | 35.36% | 33.04% | 25.47% | 17.78% |
| Free Cash Flow Growth | -132.14% | 27.45% | 84.82% | -1,218.00% |
| Safety | ||||
| Net Debt / EBITDA | 2.63 | -1.62 | -0.92 | -3.78 |
| Interest Coverage | -2.72 | -9.37 | -2.51 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 58.30 | -176.99 | -208.99 | -217.26 |